Sai Life Sciences (NSE:SAILIFE, BOM:544306) has inaugurated Unit VI, a veterinary active pharmaceutical ingredient (API) manufacturing facility, at Bidar in Karnataka, India, according to a Thursday filing with the Indian bourses.
The unit is located adjacent to the company's flagship Unit IV site in Bidar and is intended to cater to global animal health companies, the company said in the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.